Key result
Central CD200Fc microinjection lowers blood pressure and attenuates neuroinflammation in stress-induced hypertension.
Why the study?
Previous proteomic screening of the rostral ventrolateral medulla in rats with stress-induced hypertension revealed significant CD200 downregulation, motivating this investigation into the role, underlying mechanisms, and therapeutic potential of targeting CD200.
Does targeting CD200 signaling in the rostral ventrolateral medulla modulate neuroinflammation and blood pressure in a rat model of stress-induced hypertension?
Does targeting CD200 signaling in the rostral ventrolateral medulla modulate neuroinflammation and blood pressure in a rat model of stress-induced hypertension?
Preclinical evidence demonstrates that neuronal CD200 loss in the rostral ventrolateral medulla promotes neuroinflammation and sympathetic overactivation in stress-induced hypertension, identifying CD200 receptor agonism (CD200Fc) as a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; hypothesis-generating for CD200 agonism in stress-induced hypertension.
Stress-induced hypertension (SIH) is a prevalent public health concern, and brain-immune crosstalk, particularly neuroinflammation-mediated sympathetic overactivation, dominates its pathogenesis. Our previous proteomic screening of the rostral ventrolateral medulla (RVLM) in SIH rats revealed significant CD200 downregulation, suggesting its regulatory function in SIH development. This study investigated CD200's role, underlying mechanisms, and the therapeutic potential of targeting CD200. We performed RVLM proteomic profiling in SIH rats, injected LV-shCD200 into the RVLM of normal rats to knock down CD200, and microinjected CD200Fc (a CD200 receptor agonist) into the RVLM of SIH rats to test its efficacy; Western blot, qRT-PCR, and immunofluorescence confirmed specific CD200 reduction in the RVLM neurons of SIH rats. Functional assays demonstrated that RVLM CD200 silencing induced neuroinflammation, M1 microglial polarization, and elevated blood pressure, whereas local CD200Fc administration reduced blood pressure and ameliorated neuroinflammation in SIH rats. Mechanistically, CD200 loss promoted M1 microglial polarization, enhancing RVLM neuronal excitability and excessive sympathetic outflow to sustain hypertension. Collectively, CD200 confers critical protection against SIH by modulating RVLM neuroinflammation and neuronal activity, and CD200Fc-activated CD200 signaling remodels RVLM brain immune crosstalk through anti-inflammatory and neuromodulatory effects as a promising therapeutic strategy for SIH.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied Stress-induced hypertension (SIH). CD200Fc microinjection and LV-shCD200 injection into the rostral ventrolateral medulla (RVLM) vs. Normal and SIH control rats was evaluated on Blood pressure, neuroinflammation, M1 microglial polarization, RVLM neuronal excitability, and sympathetic outflow. Local CD200Fc microinjection into the rostral ventrolateral medulla reduced blood pressure and ameliorated neuroinflammation in rats with stress-induced hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: